Serum cytokines in astrocytic brain tumors: a prospective study

References

• Shan Y, He X, Song W, Han D, Niu J, Wang J. Role of IL-6 in the invasiveness and prognosis of glioma. Int J Clin Exp Med 2015;15:9114–20.
   Google Scholar
• Ostrom QT, Gittleman H, Xu J, et al. CBTRUS statistical report: primary brain and other central nervous system tumors diagnosed in the United States in 2009–2013. Neuro Oncol 2016; 18:v1–v75.
   PubMed Web of Science ®Google Scholar
• Dubois LG, Campanati L, Righy C, et al. Gliomas and the vascular fragility of the blood brain barrier. Front Cell Neurosci 2014;8:418.
   PubMed Web of Science ®Google Scholar
• Yeung YT, McDonald KL, Grewal T, Munoz L. Interleukins in glioblastoma pathophysiology: implications for therapy. Br J Pharmacol 2013;168:591–606.
   PubMed Web of Science ®Google Scholar
• Chen L, Shi Y, Zhu X, et al. IL‑10 secreted by cancer‑associated macrophages regulates proliferation and invasion in gastric cancer cells via c‑Met/STAT3 signaling. Oncol Rep 2019;42:595–604.
   PubMed Web of Science ®Google Scholar
• Huettner C, Czub S, Kerkau S, Roggendorf W, Tonn JC. Interleukin 10 is expressed in human gliomas in vivo and increases glioma cell proliferation and motility in vitro. Anticancer Res 1997;17:3217–24.
   PubMed Web of Science ®Google Scholar
• Christofides A, Kosmopoulos M, Piperi C. Pathophysiological mechanisms regulated by cytokines in gliomas. Cytokine 2015;71:377–84.
   PubMed Web of Science ®Google Scholar
• Mostofa AG, Punganuru SR, Madala HR, Al-Obaide M, Srivenugopal KS. The process and regulatory components of inflammation in brain oncogenesis. Biomolecules 2017;7:34.
   PubMed Web of Science ®Google Scholar
• Mantovani A, Allavena P, Sica A, Balkwill F. Cancer-related inflammation. Nature 2008;454:436–44.
   PubMed Web of Science ®Google Scholar
• Solinas G, Marchesi F, Garlanda C, Mantovani A, Allavena P. Inflammation-mediated promotion of invasion and metastasis. Cancer Metastasis Rev 2010;29:243–8.
   PubMed Web of Science ®Google Scholar
• Raychaudhuri B, Vogelbaum MA. IL-8 is a mediator of NF-κB induced invasion by gliomas. J Neurooncol 2011;101:227–35.
   PubMed Web of Science ®Google Scholar
• Dinarello CA. Interleukin-1 in the pathogenesis and treatment of inflammatory diseases. Blood 2011;117:3720–32.
   PubMed Web of Science ®Google Scholar
• Fukaya R, Ohta S, Yaguchi T, et al. Mif maintains the tumorigenic capacity of brain tumor-initiating cells by directly inhibiting p53. Cancer Res 2016;76:2813–23.
   PubMed Web of Science ®Google Scholar
• Ghosh S, Paul A, Sen E. Tumor necrosis factor α-induced hypoxia-inducible factor 1α-β-catenin axis regulates major histocompatibility complex class I gene activation through chromatin remodeling. Mol Cell Biol 2013;33:2718–31.
   PubMed Web of Science ®Google Scholar
• Grauer O, Poschl P, Lohmeier A, Adema GJ, Bogdahn U. Toll-like receptor triggered dendritic cell maturation and IL-12 secretion are necessary to overcome T-cell inhibition by glioma-associated TGF-beta2. J Neurooncol 2007;82:151–61.
   PubMed Web of Science ®Google Scholar
• Gadani SP, Cronk JC, Norris GT, Kipnis J. IL-4 in the brain: a cytokine to remember. J Immunol 2012;189:4213–9.
   PubMed Web of Science ®Google Scholar
• Gabrilovich DI, Ostrand-Rosenberg S, Bronte V. Coordinated regulation of myeloid cells by tumours. Nat Rev Immunol 2012;12:253–68.
   PubMed Web of Science ®Google Scholar
• Neurath MF, Finotto S. IL-6 signaling in autoimmunity, chronic inflammation and inflammation-associated cancer. Cytokine Growth Factor Rev 2011; 22:83–9.
   PubMed Web of Science ®Google Scholar
• Wang G, Ye Y, Zhang X, Song J. Bradykinin stimulates IL-6 production and cell invasion in colorectal cancer cells. Oncol Rep 2014; 32:1709–14.
   PubMed Web of Science ®Google Scholar
• Chen W, Gao Q, Han S, Pan F, Fan W. The CCL2/CCR2 axis enhances IL-6-induced epithelial-mesenchymal transition by cooperatively activating STAT3-Twist signaling. Tumour Biol 2015;36:973–81.
   PubMedGoogle Scholar
• Xu H, Lai W, Zhang Y, et al. Tumor-associated macrophage-derived IL-6 and IL-8 enhance invasive activity of LoVo cells induced by PRL-3 in a KCNN4 channel-dependent manner. BMC Cancer 2014;14:330.
   PubMed Web of Science ®Google Scholar
• Hotfilder M, Knupfer H, Mohlenkamp G, et al. Interferon-gamma increases IL-6 production in human glioblastoma cell lines. Anticancer Res 2000;20:4445–50.
   PubMed Web of Science ®Google Scholar
• Li R, Li G, Deng L, et al. IL-6 augments the invasiveness of U87MG human glioblastoma multiforme cells via up-regulation of MMP-2 and fascin-1. Oncol Rep 2010; 23:1553–9.
   PubMed Web of Science ®Google Scholar
• Michaud-Levesque J, Bousquet-Gagnon N, Beliveau R. Quercetin abrogates IL-6/STAT3 signaling and inhibits glioblastoma cell line growth and migration. Exp Cell Res 2012; 318:925–35.
   PubMed Web of Science ®Google Scholar
• Kumar R, Kamdar D, Madden L, et al. Th1/Th2 cytokine imbalance in meningioma, anaplastic astrocytoma and glioblastoma multiforme patients. Oncol Rep 2006;15:1513–6.
   PubMed Web of Science ®Google Scholar
• Albulescu R, Codrici E, Popescu ID, et al. Cytokine patterns in brain tumour progression. Mediators Inflamm 2013;2013:979748.
   PubMed Web of Science ®Google Scholar
• Kulbe H, Hagemann T, Szlosarek PW, Balkwill FR, Wilson JL. The inflammatory cytokine TNF-a upregulates chemokine receptor expression on ovarian cancer cells. Cancer Res 2005;65:10355–62.
   PubMed Web of Science ®Google Scholar
• Pollard JW. Tumour-educated macrophages promote tumour progression and metastasis. Nat Rev Cancer 2004; 4:71–8.
   PubMed Web of Science ®Google Scholar
• Suzuki T, Maruno M, Wada K, et al. Genetic analysis of human glioblastomas using a genomic microarray system. Brain Tumor Pathol 2004;21:27–34.
   PubMedGoogle Scholar
• Hambardzumyan D, Bergers G. Glioblastoma: defining tumor niches. Trends Cancer 2015;1:252–65.
   PubMed Web of Science ®Google Scholar
• De Vleeschouwer S, Bergers G, Glioblastoma: to target the tumor cell or the microenvironment? In: De Vleeschouwer S, editor. Glioblastoma. Brisbane (AU): Codon Publications; 315-340. 2017 Sep 27. Chapter 16. Available from: https://www.ncbi.nlm.nih.gov/books/NBK469984/doi:10.15586/codon.glioblastoma.2017.ch16.
   Google Scholar
• Husain H, Savage W, Grossman SA, et al. Pre- and post-operative plasma glial fibrillary acidic protein levels in patients with newly diagnosed gliomas. J Neurooncol 2012;109:123–7.
   PubMed Web of Science ®Google Scholar
• Toft AD, Falahati A, Steensberg A. Source and kinetics of interleukin-6 in humans during exercise demonstrated by a minimally invasive model. Eur J Appl Physiol 2011;111:1351–9.
   PubMed Web of Science ®Google Scholar
• Huhn RD, Radwanski E, Gallo J, et al. Pharmacodynamics of subcutaneous recombinant human interleukin-10 in healthy volunteers. Clin Pharmacol Ther 1997;62:171–80.
   PubMed Web of Science ®Google Scholar
• Oliver JC, Bland LA, Oettinger CW, et al. Cytokine kinetics in an in vitro whole blood model following an endotoxin challenge. Lymphokine Cytokine Res 1993;12:115–20.
   PubMedGoogle Scholar
• Tanabe K, Matsushima-Nishiwaki R, Yamaguchi S, Iida H, Dohi S, Kozawa O. Mechanisms of tumor necrosis factor-alpha-induced interleukin-6 synthesis in glioma cells. J Neuroinflammation 2010;7:16.
   PubMed Web of Science ®Google Scholar
• Atan A, Güzel Ö. How should prostate specific antigen be interpreted? Turk J Urol 2013;39:188–93.
   PubMedGoogle Scholar
• Hall C, Clarke L, Pal A, et al. A review of the role of carcinoembryonic antigen in clinical practice. Ann Coloproctol 2019;35:294–305.
   PubMed Web of Science ®Google Scholar
• Holdhoff M, Yovino SG, Boadu O, Grossman SA. Blood-based biomarkers for malignant gliomas. J Neurooncol 2013;113:345–52.
   PubMed Web of Science ®Google Scholar